Jonathan Rubin
Hoofd Techniek/Wetenschap/O&O bij SUPERNUS PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Jonathan Rubin
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA
26
| Subsidiary | Pharmaceuticals: Major | 26 |
| Public Company | Pharmaceuticals: Major | 17 | |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.
9
| Extinct | Pharmaceuticals: Major | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jonathan Rubin via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Pharmaceuticals: Other | Chief Executive Officer Chairman | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Secretary | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Sales & Marketing | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| TRANSLATE BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Drexel University | College/University | Masters Business Admin Undergraduate Degree | |
| Albright College | College/University | Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Graduate Degree | |
| Florida International University | College/University | Undergraduate Degree | |
| Suffolk University | College/University | Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Masters Business Admin Doctorate Degree | |
| POINTER TELOCATION LTD. | Other Consumer Services | Director/Board Member | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| State University of New York at Downstate Medical Center | College/University | Undergraduate Degree Doctorate Degree | |
Orderman GmbH
 Orderman GmbH Electronic Equipment/InstrumentsElectronic Technology Orderman GmbH develops handheld point of sale terminals. The company's radio ordering and billing systems are used in restaurants, cafes, arenas, stadiums, and bars and nightclubs. Orderman GmbH is the global market leader of radio ordering systems in the hospitality industry. The company was founded in 1993 and is headquartered in Salzburg, Austria. | Electronic Equipment/Instruments | Corporate Officer/Principal | |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Israeli Air Force | Corporate Officer/Principal | ||
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Founder Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
EndoSpan Ltd.
 EndoSpan Ltd. Pharmaceuticals: MajorHealth Technology EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Samson Neurosciences Ltd. | Director/Board Member | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Doctorate Degree | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Chief Operating Officer Consultant / Advisor | |
Yazamtech Ltd.
 Yazamtech Ltd. Miscellaneous Commercial ServicesCommercial Services Yazamtech Ltd. provides comprehensive cyber security solutions to protect against modern threats such as APT, Zero Day Attacks, Ransomware, and Data Leakage. The private company is based in Raanana, Israel. The Israeli company's solution involves secured transference between isolated networks, allowing for file transference between two separated networks while maintaining full communication separation between them. Yazamtech's proprietary products manage infected file streams from entering the network by either blocking them or actively disarming their content and reconstructing them securely prior to entering the network. The company offers a distributor program with special incentives and programs for managing resellers, processing orders, and marketing their products. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Elisra, Inc. | President | ||
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chairman Director/Board Member | |
| DEVONIAN HEALTH GROUP INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Herd Moonitor Ltd. | Chief Executive Officer | ||
Nasus Pharma Ltd.
 Nasus Pharma Ltd. Medical SpecialtiesHealth Technology Nasus Pharma Ltd. is a pharmaceutical company based in Tel Aviv, Israel. The Israeli company specializes in developing intranasal powder products to assist patients in acute emergency situations such as opioid overdose and anaphylactic shock. The private company's portfolio includes intranasal naloxone and intranasal epinephrine, as well as several preclinical programs. Nasus Pharma's unique patented technology creates a unique combination of two homogenous particle populations. The company has presented clinical results at various conferences and are dedicated to addressing acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo. | Medical Specialties | Founder |
Statistieken
Internationaal
| Verenigde Staten | 34 |
| Israël | 11 |
| Frankrijk | 3 |
| Ierland | 2 |
| Oostenrijk | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
| Finance | 2 |
Operationeel
| Director/Board Member | 197 |
| Corporate Officer/Principal | 135 |
| Independent Dir/Board Member | 69 |
| Undergraduate Degree | 47 |
| Chief Tech/Sci/R&D Officer | 37 |
Sterkste connecties
| Insiders | |
|---|---|
| Yuval Yanai | 37 |
| Ian Clark | 35 |
| Georges Gemayel | 33 |
| Charles Newhall | 29 |
| Gwen Melincoff | 20 |
| David Stout | 19 |
| Frédéric Chéreau | 17 |
| Kathryn Gregory | 16 |
| Udi Gilboa | 16 |
| John Siebert | 16 |
| Jack Khattar | 16 |
| Frederick Hudson | 14 |
| Arieh Ben-Yosef | 14 |
| Joao Siffert | 14 |
| Amir Efrati | 13 |
- Beurs
- Insiders
- Jonathan Rubin
- Bedrijfsconnecties
